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Summary 
The tissue-specific extinguisher locus TSEl, a domi- 
nant negative regulator of transcription in somatic cell 
hybrids, acts via a CAMP response element (CRE) to 
repress activity of a hepatocyte-specific enhancer. 
Guided by the antagonism between TSEl and CAMP- 
mediated signal transduction, we identified the regula- 
tory subunit Rla of protein kinase A (PKA) as the prod- 
uct of the TSEl locus. The evidence derives from 
concordant expression of Rla mRNA and TSEl genetic 
activity, high resolution mapping of the Rla gene and 
TSEl on human chromosome 17, and the ability of 
a transfected Rla cDNA to generate a phenocopy of 
TSEl-mediated extinction. The mechanism of TSEll 
Rla-mediated extinction involves repression of basal 
PKA activity, reduced phosphorylation of CREB at 
Ser-133, and a corresponding reduction of in vivo pro- 
tein binding at the target CRE. 
Introduction 
Fusion of distinctly differentiated somatic ceils usually re- 
sults in the loss of tissue-specific gene products of either 
parent, a phenomenon termed extinction. The concept 
that diffusible factors control cell type-specific gene ex- 
pression in trans was originally derived from such cell fu- 
sion experiments (for reviews see Davis and Adelberg, 
1973; Davidson, 1974; Gourdeau and Fournier, 1990). 
These systems provide a genetic approach for identifying 
trans-dominant regulatory factors. To date, a genetic anal- 
ysis of extinction has been performed primarily in the hepa- 
toma x fibroblast hybrid cell system. Killary and Fournier 
(1984) identified a locus on mouse chromosome 11 and 
its human homolog, chromosome 17, the tissue-specific 
extinguisher 1 (TSEl), which coordinately represses hepa- 
tocyte-specific expression of several genes, including tyro- 
sine aminotransferase (TAT) and phosphoenolpyruvate 
carboxykinase (PEPCK) (Lem et al., 1988; Thayer and 
Fournier, 1989; Ruppert et al., 1990). All of the genes re- 
pressed by TSEl are normally inducible via the CAMP 
signal transduction pathway (Ruppert et al., 1990). Other 
extinguisher loci regulate expression of distinct sets of 
genes in hepatic cells, as all liver-specific traits are extin- 
guished in karyotypically complete hepatoma x fibroblast 
hybrids (Chin and Fournier, 1987). For example, Tse-2 on 
mouse chromosome 1 represses expression of the serum 
albumin and alcohol dehydrogenase genes (Petit et al., 
1986; Chin and Fournier, 1989). 
Hepatoma microcell hybrids and deletion hybrids 
(Leach et al., 1989) that retain only human chromosome 
17 or fragments thereof made it possible to analyze TSEl- 
specific extinction effects, for example, to identify the tar- 
get sequence for repression by TSEl in the TAT gene. A 
cyclic AMP response element (CRE), an essential compo- 
nent of a hepatocyte-specific enhancer located 3.6 kb up- 
stream of the TAT transcription start site, mediates repres- 
sion byTSE1 (Boshartet al., 1990). InductionviathecAMP 
pathway reverses TSEl -mediated repression of CRE ac- 
tivity and gene expression (Thayer and Fournier, 1989; 
Boshart et al., 1990; Ruppert et al., 1990). This functional 
antagonism between TSEl and the CAMP pathway is re- 
flected by corresponding changes in protein binding in 
vivo at the CRE of the TAT gene. Increased protein binding 
at the TATCRE upon CAMP induction is also observed in 
vitro using crude hepatoma extracts (Weih et al., 1990). 
We have suggested that TSEl inhibits posttranslational 
modification, e. g., phosphorylation of a CRE-binding pro- 
tein (CREB) by interfering in the CAMP signal transduction 
pathway (Boshart et al., 1990). Guided by this working 
hypothesis, we searched for the product of theTSE1 locus. 
As CAMP levels are not affected by TSEl (Thayer and 
Fournier, 1989; M. B., unpublished data), we could ex- 
clude a mechanism lowering CAMP levels and therefore 
acting upstream of protein kinase A (PKA) in the pathway. 
Consequently, we considered PKA inhibiting activities and 
protein phosphatases as promising candidates. The holo- 
enzyme of PKA is a tetramer consisting of two regulatory 
and two catalytic subunits and is inactive in the absence 
of CAMP. Activation occurs when two CAMP molecules 
bind to each regulatory subunit, eliciting a reversible con- 
formational change that releases active catalytic subunits 
(Taylor et al., 1990). Thus, regulatory subunits are condi- 
tional inhibitors of C. Four distinct regulatory subunit 
genes have been identified, and they are differentially ex- 
pressed (for review see McKnight et al., 1988a, 1988b). 
Here we provide evidence that the regulatory subunit Rla 
of PKA is the product of the TSEl locus. 
Results 
Basal PKA Activity Is Reduced in TSEl’ Hybrids 
Owing to the functional antagonism between TSEl- 
mediated extinction and CAMP signal transduction (Bos- 
hart et al., 1990) we tried to identify targets of TSEl action 
in the CAMP pathway. We measured PKA activity in ex- 
tracts from 7AD7 (TSEl-) and 7AE27 (TSEl+) hepatoma 
hybrid cells. These microcell hybrids retain part of human 
chromosome 17 with or without the chromosomal segment 
carrying human TSEl on a rat hepatoma background 
(Leach et al., 1989). Basal PKA activity without addition of 
CAMP was 7-fold lower in 7AE27 (TSEl+) cells (included in 
Table 1). Addition of 5 PM CAMP abolished this difference, 
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Figure 1. The Rla Gene Maps to Human Chromosome 17 
Genomic DNAs were digested with EcoRl or Hindlll as indicated and 
8 ng was analyzed by Southern blot hybridization with a 40-mer oligo- 
nucleotide probe complementary to nucleotides 23-62 of the human 
Rla coding region (Sandberg et al., 1987). This is within the least 
conserved part of the regulatory subunit sequence, so that the Rlf3 
gene or RII genes were not detected. The human probe weakly cross- 
hybridized to a rat Rla restriction fragment, which provided an internal 
reference. The result was confirmed with Pstl- and Sstl-digested sam- 
ples (not shown). 
indicating that expression of the catalytic subunit was simi- 
lar in both cell lines. This was confirmed by measuring 
catalytic subunit mRNA levels (data not shown). As one 
explanation, we considered the possibility that increased 
regulatory subunit expression led to reduced basal PKA 
activity in 7AE27 (TSEI +) cells. This might occur if TSEl 
either up-regulated a regulatory subunit encoded by the 
rat hepatoma genome or if TSEl itself encoded a human 
regulatory subunit. Therefore, we performed Southern blot 
hybridizations to test whether any of the four regulatory 
subunit genes mapped to human chromosome 17. With 
a mouse Rla probe (Clegg et al., 1987) we detected a 
human-specif ic restriction fragment in genomic DNA from 
7AE27 (TSEl+) but not 7AD7 (TSEl-) ceils (data not 
shown). This result was confirmed with an oligonucleotide 
probe specific for human Rla (Figure 1). Thus, the human 
Rla gene and TSEl both map to a segment of chromo- 
some 17 retained in 7AE27 (TSEl+) but not in 7AD7 
(TSEl-) cells. A previous report had assigned a sequence 
recognized by an Rla probe to human chromosome 7 
(Scambler et al., 1987). It is now clear that this sequence 
is the closely related RI8 gene expressed specifically in 
neuronal t issues (Clegg et al., 1988 and G. S. McKnight, 
personal communication). RI18 has also been mapped to 
human chromosome 7 (Scambler et al., 1987). 
Expression of Rla Correlates with 
the TSEl Phenotype 
Using a human-specifio Rla oligonucleotide probe, we de- 
tected Rla mRNA in 7AE27 (TSEl+), but not 7AD7 (TSEl-) 
cells (Figure 2B). Two human Rla mRNAs (Sandberg et 
al., 1987) are generated by differential usage of polyadeny- 
lation signals (Sandberg et al., 1990). The Rla mRNAs 
encoded by the rat genome were detected using a rat- 
specific Rla oligonucleotide probe. Three rat Rla mRNAs, 
also generated by differential polyadenylation (Oyen et 
al., 1988) were expressed at a very low level, and their 
expression was not affected by the presence of human 
TSEl (Figure 2A). The levels of rat Rlla and rat RI18 
mRNAs, as detected by specific oligonucleotide probes 
(Sandberg et al., 1988; Oyen et al., 1989) were also identi- 
cal in 7AD7 (TSEl-) and 7AE27 (TSEl+) cells (data not 
shown). Treatment of the cells with a CAMP analog or 
glucocorticoids did not change the level of any of the regu- 
latory subunit mRNAs. However,  high levels of Rla mRNA 
were found in both rat f ibrosarcoma cells (XC) and pri- 
mary human fibroblasts (Figures 2A and 2C). Thus, high 
level expression of Rla mRNAs in fibroblasts and hepa- 
toma x fibroblast microcell hybrids correlates with the 
TSEl’ phenotype of the cells. 
We confirmed this correlation by analyzing a number of 
independently derived microcell hybrid clones (Figure 2C). 
The level of Rla mRNA in different TSEl’ hybrids was 
remarkably uniform.and was maintained after subcloning 
and extensive passaging (compare 7AE27 and 7AE27/8, 
Figure 2C). This reflects the chromosomal stability of the 
microcell hybrids used in this work. In all TSEl+ hybrids, 
the level of Rla mRNA was about half the level in primary 
human fibroblasts. This was expected from gene dosage, 
as most microcell hybrids contain a single copy of human 
chromosome 17or part of it (R. E. K. Fournier, unpublished 
data). Apparently, in hybrids the Rla gene on the trans- 
ferred fibroblast chromosome continues to be expressed 
at a high level irrespective of low level expression of the 
Rla alleles in the hepatoma recipient cell. Expression of 
TSEl activity must also be stably maintained by the fibro- 
blast chromosome that mediates extinction. 
Rla and TSEl Colocalize to a Small Segment 
of Human Chromosome 17 
To determine whether Rla mapped to the TSEl locus, the 
map position of Rla was established relative to a set of 
cloned DNA markers for 17q23-24, which had been used 
to construct a physical map of the chromosome segment 
that includes human TSEl. The isolation of these DNA 
markers and the construction okthe physical map will be 
described in detail elsewhere (B. E. K. Fournier, personal 
communication). In brief, chromosome fragment-con- 
taining hybrids with deletion breakpoints in 17q (Leach et 
al., 1989) had been scored for retention of the various 
DNA markers by Southern blot hybridization. The TSEl 
phenotype of the cells had been determined by quantita- 
tion of TAT and PEPCK mRNA levels (R. E,: K. Fournier, 
personal communicationf. WgRaGe used the Southern 
blot shown in Figure 3 @position Rla relative to the various 
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Figure 2. Expression of Rla mRNA Correlates with the TSEI- 
Mediated Extinction Phenotype 
(A and B) Total RNA (10 ug) from uninduced (-) or induced (c, p-chlo- 
rophenylthio-CAMP; d, dexamethasone; c+d, both) cells was analyzed 
by Northern blot hybridization. Induction conditions were as described 
by Ruppert et al. (1990). For (A), the probe was a 37-mer oligonucleo- 
tide complementary to nucleotides 118-154 of the rat Rla cDNA se- 
quence (Kuno et al., 1987). The sizes of the three rat Rla mRNAs were 
reported as 3.2 kb, 2.9 kb, and 1.7 kb (@yen et al., 1988). The human 
Rla probe used for (B) was the same as in Figure 1. and cross- 
hybridized with rat Rla mRNA (see XC fibrosarcoma lane). The sizes 
of the two human Rla mRNAs were 3.0 kb and 1.5 kb according to 
Sandberg et al. (1987). 
(C)The Northern blot (15 pg total RNA) was hybridized with a 40-mer 
oligonucleotide complementary to a sequence 100% conserved be- 
tween the rat, mouse, and human Rla coding regions (nucleotides 
562-601 of the human Rlu cDNA sequence of Sandberg et al., 1987) 
to allow direct comparison of the Rla mRNA levels in the various cell 
lines. FTH(I7)K, FTH(17)V, and 355(17)1 are rat hepatoma x human 
fibroblast microcell hybrids retaining human chromosome 17. 
355(17)Bl is a back-selectant from 355(17)1 that has lost the human 
chromosome. 7AD7/5 and 7AE27/8 are subclones from the deletion 
hybrids 7AD7 (TSE7-) and 7AE27 (TSEI’), respectively (Lem et al., 
1988; Leach et al., 1989; Boshartet al., 1990). Human fibroblasts were 
derived from an oral mucosa biopsy. Clone 17 (#17) is an FTOLB rat 
hepatoma transfectant overexpressing mouse Rla(mut). The TSEl 
phenotype of the cell lines (as determined by measuring TAT mRNA 
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Figure 3. Colocalization of Rla and TSEi on Human Chromosome 17 
The results of marker analysis are summarized in the upper part of the 
figure. Nine DNA markers from the 17q23-24 region were arranged 
using Southern blot hybridization data from deletion hybrids described 
in Leach et al. (1989). TSEl was phenotyped by measuring TAT and 
PEPCK mRNAs. EcoRCdigested DNA samples from these deletion 
hybrids were subjected to Southern blot hybridization with the human 
Rla oligonucleotide probe described in Figure 1. Two copies of the 
chromosomal segment carrying human Rla seem to be retained in 
deletion hybrids 7AD6 and 7AE6. The size marker is h DNA cut with 
Hindlll. In some lanes partial digestion products are visible as addi- 
tional bands in the 9-10 kb region. 
DNA markers and to TSEl, resulting in the map shown 
schematically in Figure 3. The Flla gene and human TSEl 
colocalized to a segment of distal 17q bounded by cosmid 
markers cF1 and cF8. Although the precise size of this 
interval is not yet known, it is likely to represent several 
hundred kilobase pairs of genomic DNA. Thus, Rla and 
TSEl colocalize to a small segment of the chromosome. 
levels [data not shown]) is indicated as + or - or n.a. (not applicable). 
Rat fibrosarcoma (XC) cells have not been tested in a fusion assay, but 
the TSEl phenotype is assigned by analogy with human and mouse 
fibroblasts. As size marker, the RNA ladder from Bethesda Research 
Laboratories was used. 
All filters were rehybridized with a rat glyceraldehyde-3-phosphate- 
dehydrogenase (GAPDH) probe (Fort et al., 1985; Ruppert et al., 1990) 
as the internal standard. The loading of human fibroblast RNA was 
controlled using ribosomal RNAs as reference (not shown). 
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Figure 4. Northern Blot Hybridization Analysisof StableTransfectants 
Expressing Mouse Rla(mut) 
Where indicated, cells were treated with 100 uM ZnCb for 18 hr. For- 
skolin (10 uM) or ethanol (0.1%) as solvent control was added 2 hr 
before RNA extraction. Total RNA (IO ug) was probed for the catalytic 
subunit C. of PKA, for the regulatory subunit Rlu, for TAT, and for 
PEPCK. The riboprobes used were described in Ruppert et al. (1990). 
All filters were rehybridized with a GAPDH probe as internal standard 
(only one example is shown). 
Overexpression of Rla in Hepatoma Cells Results 
in a Phenocopy of TSEl-Mediated Extinction 
To determine whether Rla overexpression could produce 
a TSEl+ phenotype, we stably introduced an expression 
vector encoding mouse Rla under control of a zinc- 
inducible metallothionein promoter (Clegg et al., 1987; 
Mellon et al., 1989; kindly provided by G. S. McKnight) into 
FTOPB cells, which are the parental cells of the microcell 
hybrids used in this work. We used an Rla cDNA with point 
mutations in each of the two CAMP-binding sites, encoding 
a protein that cannot bind CAMP. Upon induction with 
CAMP, the mutant Rla subunit does not dissociate from the 
holoenzyme to release active catalytic subunits (Correll et 
al., 1989; Woodford et al., 1989). This allowed us to moni- 
tor the fraction of catalytic subunits bound to endogenous 
versus transfected regulatory subunits by measuring the 
residual CAMP response. Twenty-four transfectant clones 
were analyzed as described in the Experimental Proce- 
dures. Data for two clones, both showing about 3- to 4-fold 
zinc inducibility of Rla(mut) mRNA expression, are pre- 
sented (Figure 4). As expected, increasing expression of 
Rla(mut) led to a reduction in basal PKA activity (Table 1). 
At high levels of Rla(mut) expression, cAMPstimulated 
kinase activity was also reduced, indicating that at this 
level of expression a significant fraction of PKA holoen- 
zyme contained mutant Rla subunits. 
Down-regulation of PKA activity by Rla overexpression 
resulted in a proportional decrease in mRNA levels of TAT 
and PEPCK (Figure 4) two genes that respond both to 
CAMP and TSEl (Lem et al., 1988; Ruppert et al., 1990). 
As both basal expression and CAMP inducibility of these 
genes depend on PKA activity, and as the TATCRE is 
essential for basal activity, CAMP response, and TSEl- 
mediated repression of a liver-specific enhancer 3.6 kb 
upstream of the TAT gene (Boshart et al., 1990; Weih et 
al., 1990) we assayed the activity of a multimer of this 
CRE in clones 17 and 21. Enhancement of the herpesvirus 
thymidine kinase promoter activity by the multimerized 
(5 x) CRE was reduced proportionally with down-regula- 
tion of PKA activity(Figure 5). The quantitative correlations 
between Rla(mut) mRNA expression, reduction of basal 
PKA activity, CRE-mediated transcriptional activation, 
and basal expression of the TAT and PEPCK mRNAs are 
shown in Figure 5. Two important conclusions can be 
drawn from these experiments: first, PKA activity not only 
mediates CAMP induction, but is required for basal expres- 
sion of both TAT and PEPCK in hepatic cells. Second, 
overexpression of Rla resulted in a phenocopy of TSEl- 
mediated extinction. For example, PEPCK mRNA levels 
are more dramatically reduced by TSEl than are TAT 
mRNA levels (Thayer and Fournier, 1989). Rla overex- 
pression in clone 21 led to complete repression of PEPCK 
mRNA, whereas the effect on TAT mRNA was less pro- 
nounced (Figures 4 and 5). The failure of complete repres- 
sion of the TAT gene might be related to the presence of 
a second liver-specific enhancer at -11 kb of the TAT gene 
that is not responsive to TSEl (Nitsch et al., 1990; D. 
Nitsch, unpublished data). Reversal of the TSEl effect by 
CAMP is another property of hepatoma microcell hybrids 
(Thayerand Fournier, 1989; Boshartet al., 1990; Ruppert 
et al., 1990). Owing to overexpression of mutant rather 
than wild-type Rla subunits in our transfectants, CAMP 
Table 1. PKA Activity in Extracts from Microcell Hybrids and Hepatoma Transfectants Expressing Rlu(mut) 
PKA-Specific Activity in pmollmin per mg (mean + SD) 
Cel! Line 
7AD7 (TSEl ) 
7AE27 (TSEl’) 
FTOZB 
Clone 17 
Clone 21 
Untreated Ceils 
Basal’ 
205 + 12 
28 f 4 
184 e 12 
84 f 5 
5-t4 
5 uM CAMP’ 
1598 f 52d 
1735 * 10d 
992 + 26 
932 f 56 
133 -c 22 
ZnCI,-Treated Cells? 
Basal’ 5 uM cAMPC 
- - 
- - 
157 f 6 1029 f 40 
8+1 435 2 0 
3&2 24 + 5 
- 
a Extracts were prepared and protein kinase was assayed in triplicates as described in the Experimental Procedures. SD, standard deviation. 
b ZnCI, (100 uM) was added to the medium 21 hr prior to harvest to induce the metallothionein promoter driving Rla(mut) expression. 
c The activities are PKA specific, as each sample was measured in parallel in the presence of the PKl(l-31) inhibitor peptide (Scott et al., 1986; 
Grove et al., 1987). Only the inhibitable activity is displayed. 
d The dose response curve for PKA activation by CAMP was not different for 7AD7 (TSEl-) and 7AE27 (TSEl’) extracts (data not shown). 
